ATS, ResMed launch fellowship
By HME News Staff
Updated Tue April 24, 2018
NEW YORK - The ATS Foundation and ResMed have partnered on a new fellowship in sleep-disordered breathing and PAP therapy. The ATS Foundation/ResMed Research Fellowship is made possible through a $100,000 contribution from ResMed. “This award can help shine a brighter light on sleep apnea—a public health crisis—and PAP therapy's role in addressing it worldwide,” said Carlos M. Nunez, MD, ResMed's chief medical officer. “When 85% of people with sleep apnea still aren't diagnosed, ResMed is proud to support high-quality research efforts to accelerate finding, testing and treating them so they can enjoy a full night's rest, better overall health and a significant reduction of life-threatening risks.” The fellowship application process will open April 26. The ATS Scientific Advisory Committee will review applications for their scientific merit, innovation, feasibility and relevance to sleep-disordered breathing and PAP therapy. The $100,000 in funding will span a two-year period, from December 2018 through December 2020.
Comments